If you want to do a good job, you must first use your tools
.
Under the background of the current pharmaceutical industry ushering in a new stage of development, pharmaceutical equipment, as the "mother machine" of drug production, has both opportunities and challenges, and industry enterprises need to continuously innovate and upgrade equipment to help pharmaceutical companies improve pharmaceutical quality
.
Pharmaceutical equipment (Image source: Pharma.
com)
As early as the "Twelfth Five-Year Plan for the Development of the Pharmaceutical Industry", it is clear in Chinese that pharmaceutical equipment is one of the five key development areas of the pharmaceutical industry, and it is necessary to improve the production level of pharmaceutical equipment, encourage the development and production of new pharmaceutical equipment that meets the requirements of pharmaceutical GMP, and provide support
for improving the level of pharmaceutical production.
In recent years, with the rapid development of the pharmaceutical industry, the upstream pharmaceutical equipment industry has received more and more attention, and a series of favorable policies and related standards have been continuously implemented
.
For example, in November 2016, the six departments jointly issued the Guidelines for the Development Planning of the Pharmaceutical Industry, which clarified the need to improve the level of
integration, continuity, automation, informatization and intelligence of pharmaceutical equipment.
The "Thirteenth Five-Year Plan for the Development of the Pharmaceutical Industry" released in November of the same year also once again emphasized the need to improve the level
of integration, continuity, automation, informatization and intelligence of pharmaceutical equipment.
Develop systematic complete sets of equipment, provide overall solutions, etc
.
In March 2018, AQSIQ and the National Standards Committee issued the General Technical Requirements for In-Place Cleaning and Sterilization of Pharmaceutical Machinery (Equipment), which stipulates the quality standards for
cleaning and sterilization of pharmaceutical machinery (equipment).
In November 2019, the National Development and Reform Commission issued the Catalogue for the Guidance of Industrial Restructuring (2019 edition), encouraging the development and production of new drugs with independent intellectual property rights, the development and production of natural medicines, and the development and production
of high-end pharmaceutical equipment.
In September 2020, the National Development and Reform Commission and other four departments jointly issued the Guiding Opinions on Expanding Investment in Strategic Emerging Industries to Cultivate and Grow New Growth Poles, which mentioned that it is necessary to focus on supporting the production of high-end equipment such as high-end medical equipment and pharmaceutical equipment, and implement pilot demonstrations
of intelligent manufacturing and intelligent construction.
In September 2021, the Action Plan for Making the Pharmaceutical Industry Bigger and Stronger (2021-2023) proposed to promote the digitalization of the pharmaceutical industry, empower pharmaceutical manufacturing with a new generation of information technology, and improve the level of automation, digitalization and intelligence of
pharmaceutical equipment.
In November of the same year, the Notice on Promoting the High-quality Development of the API Industry Implementation Plan was issued, requiring the promotion of cross-field resource sharing and cooperation, strengthening the integration and cooperation between bioengineering, fine chemicals, hazardous waste disposal, pharmaceutical equipment and API enterprises, and improving the modernization level of
the industrial chain.
.
.
.
.
.
.
.
As an important starting point for the overall development of the pharmaceutical industry, the pharmaceutical equipment industry will play a more important role
in the overall progress of the national medical and health level.
From the perspective of a series of policy directions in recent years, the entire domestic pharmaceutical equipment industry will be transformed and upgraded
from low-end to high-end.
The industry believes that it is imperative to upgrade the structure of the pharmaceutical equipment industry, and improving automation, digitalization and intelligence is still the main direction
of the development of the pharmaceutical equipment industry in the future.
It is understood that in response to the general trend of intelligent manufacturing development, at present, domestic pharmaceutical equipment enterprises represented by leading enterprises are vigorously promoting intelligent transformation to achieve steady improvement
in development quality and efficiency.
For example, the overall solution of sterile freeze-dried API isolator newly created by Chutian Technology is a research and development innovation
carried out around many pain points such as improving the quality of drug production and improving the operating environment of pharmaceutical personnel.
In addition, in the intelligent manufacturing workshop of Chutian Technology, through intelligent operation, unattended, the equipment utilization rate has increased from about 25% to about 70%, greatly improving production quality and efficiency
.
Coincidentally, Dongfulong is also promoting the pharmaceutical industry 4.
0, the company uses digital software to plan the layout of the factory, design the production line, and carry out virtual planning simulation and optimization verification of the workshop process, so as to optimize the layout of the workshop, optimize the material distribution, optimize the number of labor and equipment, save manufacturing costs, shorten the development cycle, and reduce the scrap rate
of product production.
For example, Canaan Technology is also committed to improving the intelligence and automation level
of pharmaceutical equipment.
On September 21, Canaan Science and Technology announced that Tianjin Canaan, a subsidiary of Canaan, intends to participate in the auction of the right
to use an industrial land in Tianjin for no more than 27 million yuan.
The company said in the announcement that the land use right is mainly used as a reserve land for biopharmaceutical system equipment industrialization projects or future new projects, and the production equipment with superior performance is configured to meet the needs of automation and intelligent production, and at the same time gives full play to the location advantages to form a good synergy with the existing production base, which is of great strategic significance
for the company to improve and strengthen the layout of biopharmaceutical equipment.
The industry believes that the rapid development of biological drugs and import substitution have brought new opportunities to the pharmaceutical equipment industry, and domestic pharmaceutical machine enterprises should seize the opportunity to develop more intelligent pharmaceutical equipment to escort drug safety and help improve
drug quality and production efficiency.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
